Earnings Call Summary | AYR WELLNESS INC(AYRWF.US) Q1 2024 Earnings Conference
Earnings Call Summary | AYR WELLNESS INC(AYRWF.US) Q1 2024 Earnings Conference
The following is a summary of the Ayr Wellness Inc. (AYRWF) Q1 2024 Earnings Call Transcript:
以下是艾爾健康公司（AYRWF）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Ayr Wellness reported sales of $118 million in Q1 2024, up 2.8% from the previous quarter and less than 1% from the prior year.
The company increased their adjusted EBITDA by $8 million year-on-year to $29.1 million, despite a slight decrease from the previous quarter.
Ayr generated an operating cash flow of $8.7 million and managed to achieve positive free cash flow despite a CapEx payment of $6.8 million.
艾爾健康報告稱，2024年第一季度的銷售額爲1.18億美元，比上一季度增長2.8％，比上年不到1％。
儘管與上一季度相比略有下降，但該公司調整後的息稅折舊攤銷前利潤同比增長了800萬美元，至2910萬美元。
艾爾創造了870萬澳元的運營現金流，儘管資本支出爲680萬美元，但仍設法實現了正的自由現金流。
Business Progress:
業務進展：
Ayr marked a year since rebranding their Florida stores, with plans to extend the rebranding in Illinois and Boston by year-end.
The company is seeing growth in their wholesale business, particularly with the relaunch of their core brands, Kynd and HAZE.
Ayr is enhancing cultivation capacity and refining operations for better inventory flow.
They are gearing for growth in key markets like Ohio, Florida and Pennsylvania as these transition from medical to adult use.
The company plans to expand retail footprint, with a target of 70 outlets in Florida by end of 2024 and two new stores in Illinois by early Q3.
They aim to maintain a 25% adjusted EBITDA margin for 2024, with hopes of generating positive cash flow.
艾爾是佛羅里達州門店品牌重塑一週年，並計劃在年底之前延長伊利諾伊州和波士頓的品牌重塑期。
該公司的批發業務正在增長，尤其是其核心品牌Kynd和HAZE的重新推出。
艾爾正在提高種植能力和煉油業務，以改善庫存流。
隨着俄亥俄州、佛羅里達州和賓夕法尼亞州等主要市場從醫療用途過渡到成人用途，他們正在爲這些市場的增長做準備。
該公司計劃擴大零售足跡，目標是到2024年底在佛羅里達州開設70家門店，到第三季度初在伊利諾伊州開設兩家新門店。
他們的目標是在2024年維持25％的調整後息稅折舊攤銷前利潤率，並希望產生正現金流。
More details: AYR WELLNESS INC IR
更多詳情： AYR WELLNESS INC
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。